Holen Sie sich die Stockscreener-App
1.23
15.17%
-0.22
Handel nachbörslich:
1.23
Finanzdaten der Valion Bio Inc-Aktie (VBIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
14.02%
6.424
|
5.634 | 2.016 | 2.338 | 1.988 |
| Operating Income/Loss |
14.02%
-6.424
|
-5.634 | -1.975 | -2.483 | -1.934 |
| Nonoperating Income/Loss |
7.11%
-0.633
|
-0.591 | 0.011 | -0.113 | 0.003 |
| Income/Loss From Continuing Operations After Tax |
13.37%
-7.057
|
-6.225 | - | - | - |
| Income/Loss From Discontinued Operations, Net Of Tax |
300.00%
-0.046
|
0.023 | - | - | - |
| Net Income/Loss |
14.53%
-7.103
|
-6.202 | -2.849 | -2.596 | -1.931 |
| Basic Average Shares |
17.21%
3.38
|
2.8837 | - | 1.3208 | 0.8813 |
| Basic Earnings Per Share |
2.69%
-2.17
|
-2.23 | - | -1.97 | -2.19 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):